Trial Profile
Clinical Trials Insight: 700052321
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jan 2010
Price :
$35
*
At a glance
- Drugs VB 201 (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- Sponsors VBL Therapeutics
- 07 Jan 2010 New trial record.